Literature DB >> 10674814

Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis.

K Kawai1, S Suzuki, Y Tabata, Y Ikada, Y Nishimura.   

Abstract

The objective of this study was to evaluate the effect of incorporation of basic fibroblast growth factor (bFGF)-impregnated gelatin microspheres into an artificial dermis on the regeneration of dermis-like tissues. When used in the free form in vivo, bFGF cannot induce sufficient wound healing activity, because of its short half-life. Therefore, sustained release of bFGF was achieved by impregnation into biodegradable gelatin microspheres. A radioisotope study revealed that incorporation of bFGF-impregnated gelatin microspheres significantly prolonged in vivo retention of bFGF in the artificial dermis. Artificial dermis with incorporated bFGF-impregnated gelatin microspheres or bFGF in solution was implanted into full-thickness skin defects on the back of guinea pigs (1.5 cm x 1.5 cm) (n = 4). Incorporation of bFGF into the artificial dermis accelerated fibroblast proliferation and capillary formation in a dose-dependent manner. However, the accelerated effects were more significant with the incorporation of bFGF-impregnated gelatin microspheres than with free bFGF at doses of 50 microg or higher. We conclude that the gelatin microsphere is a promising tool to accelerate bFGF-induced tissue regeneration in artificial dermis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674814     DOI: 10.1016/s0142-9612(99)00207-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  24 in total

Review 1.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  Gelatin microspheres crosslinked with genipin for local delivery of growth factors.

Authors:  Luis Solorio; Christopher Zwolinski; Amanda W Lund; Megan J Farrell; Jan P Stegemann
Journal:  J Tissue Eng Regen Med       Date:  2010-10       Impact factor: 3.963

Review 3.  Macroscale delivery systems for molecular and cellular payloads.

Authors:  Cathal J Kearney; David J Mooney
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

4.  Controlled release of an extract of Calendula officinalis flowers from a system based on the incorporation of gelatin-collagen microparticles into collagen I scaffolds: design and in vitro performance.

Authors:  Ronald A Jiménez; Diana Millán; Edward Suesca; Alejandro Sosnik; Marta R Fontanilla
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

5.  Feasibility study of corticosteroid treatment for esophageal ulcer after EMR in a canine model.

Authors:  Michitaka Honda; Tatsuo Nakamura; Yoshio Hori; Yoshiki Shionoya; Kazumichi Yamamoto; Yuji Nishizawa; Fumitsugu Kojima; Keiji Shigeno
Journal:  J Gastroenterol       Date:  2011-05-20       Impact factor: 7.527

6.  Tissue regeneration using macrophage migration inhibitory factor-impregnated gelatin microbeads in cutaneous wounds.

Authors:  Yunan Zhao; Tadamichi Shimizu; Jun Nishihira; Yoshikazu Koyama; Toshihiro Kushibiki; Ayumi Honda; Hirokazu Watanabe; Riichiro Abe; Yasuhiko Tabata; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Directing cell migration in continuous microchannels by topographical amplification of natural directional persistence.

Authors:  Young-Gwang Ko; Carlos C Co; Chia-Chi Ho
Journal:  Biomaterials       Date:  2012-10-23       Impact factor: 12.479

8.  Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function.

Authors:  Jitka A I Virag; Marsha L Rolle; Julia Reece; Sandrine Hardouin; Eric O Feigl; Charles E Murry
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

9.  Use of triethylcitrate plasticizer in the production of poly-L-lactic acid implants with different degradation times.

Authors:  S M N Scapin; D R M Silva; P P Joazeiro; M C Alberto-Rincon; R M Luciano; E A R Duek
Journal:  J Mater Sci Mater Med       Date:  2003-07       Impact factor: 3.896

10.  Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2.

Authors:  Marian H Hettiaratchi; Tobias Miller; Johnna S Temenoff; Robert E Guldberg; Todd C McDevitt
Journal:  Biomaterials       Date:  2014-05-28       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.